This resolution calls on the attorney general to intensify investigations into anticompetitive practices within the healthcare industry, particularly focusing on issues such as price-fixing and market allocation. It highlights the historical context of antitrust laws, referencing past Supreme Court decisions that have upheld the enforcement of these laws against healthcare entities, including pharmaceutical companies. The resolution points out the significant disparities in healthcare pricing within the state, noting that some pharmaceutical prices are considerably higher than in other regions, and that healthcare costs have escalated to represent a substantial portion of the economy.

Furthermore, the resolution emphasizes the importance of ensuring compliance with antitrust laws to protect consumers and maintain fair market practices in the healthcare sector. It urges the attorney general not only to take action against identified anticompetitive behaviors but also to publicly disclose the rationale behind any decisions not to pursue legal action in such cases. This transparency is aimed at fostering accountability and trust in the enforcement of laws designed to promote fair competition in healthcare.